114
Participants
Start Date
February 29, 2016
Primary Completion Date
July 31, 2016
Study Completion Date
August 31, 2016
patiromer
8.4 g/day starting dose, administered orally
Investigator Site 37, Flushing
Investigator Site 30, Edgewater
Investigator Site 10, Hialeah
Investigator Site 15, Miami
Investigator Site 13, Hollywood
Investigator Site 18, Pembroke Pines
Investigator Site 43, Miami
Investigator Site 16, Lauderdale Lakes
Investigator Site 27, Tampa
Investigator Site 40, Jackson
Investigator Site 23, Flint
Investigator Site 39, Aurora
Investigator Site 34, Kansas City
Investigator Site 36, Norman
Investigator Site 33, Dallas
Investigator Site 26, San Antonio
Investigator Site 29, San Antonio
Investigator Site 28, San Antonio
Investigator Site 25, San Antonio
Investigator Site 24, Denver
Investigator Site 44, Meridian
Investigator Site 22, Salt Lake City
Investigator Site 41, Las Vegas
Investigator Site 21, San Dimas
Investigator Site 38, Palm Springs
Investigator Site 20, Riverside
Investigator Site 11, Huntington Beach
Investigator Site 12, Fountain Valley
Investigator Site 17, Lauderdale Lakes
Relypsa, Inc.
INDUSTRY